SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-21-057008
Filing Date
2021-11-15
Accepted
2021-11-15 16:11:45
Documents
13
Period of Report
2021-11-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K sprb-8k_20211115.htm   iXBRL 8-K 40129
2 EX-99.1 sprb-ex991_6.htm EX-99.1 347339
  Complete submission text file 0001564590-21-057008.txt   537126

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA sprb-20211115.xsd EX-101.SCH 5721
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE sprb-20211115_lab.xml EX-101.LAB 20078
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE sprb-20211115_pre.xml EX-101.PRE 11961
6 EXTRACTED XBRL INSTANCE DOCUMENT sprb-8k_20211115_htm.xml XML 3691
Mailing Address 2001 JUNIPERO SERRA BLVD., SUITE 640 DALY CITY CA 94104
Business Address 2001 JUNIPERO SERRA BLVD., SUITE 640 DALY CITY CA 94104 (415) 294-1687
SPRUCE BIOSCIENCES, INC. (Filer) CIK: 0001683553 (see all company filings)

IRS No.: 812154263 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39594 | Film No.: 211410660
SIC: 2834 Pharmaceutical Preparations